Results 201 to 210 of about 67,280 (303)

Frontiers of Synchrotron Methods for Actinide Science

open access: yesChemistry–Methods, EarlyView.
This article explores the application of synchrotron radiation techniques ‐ XAS, XES, HERFD, RIXS, and XRD ‐ to investigate actinide materials. It provides insights into electronic structures, oxidation states, and phase transitions, emphasizing the transformative role of these techniques in advancing nuclear materials research, environmental safety ...
Damien Prieur   +7 more
wiley   +1 more source

Direct Quantification of Ammonia and Alkylamines in Aqueous Environments Using Solid‐Phase Microextraction‐Gas chromatography‐Mass spectrometry

open access: yesChemistry–Methods, EarlyView.
Fast and Facile! The use of a solid‐phase microextraction fiber allows direct sampling of aqueous solutions of ammonia for quantification using gas chromatography‐mass spectrometry (GC‐MS). The technique is insensitive to the presence of organic cosolvents or transition‐metal ions, making it particularly well suited for the analysis of catalytic ...
Doha Zidouhia   +2 more
wiley   +1 more source

First‐in‐Human Study of Merotocin, a Short‐Acting Peptidic Oxytocin Receptor Agonist for Lactation Support

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Endogenous oxytocin plays an important role in lactation, but its effectiveness as an exogenous galactagogue has been modest due to dose‐limiting side effects related to off‐target effects at the vasopressin V2 receptor. Merotocin (FE 202767) is a short‐acting peptidic oxytocin receptor agonist with the potential to aid mothers experiencing ...
Yu Bagger   +4 more
wiley   +1 more source

Measurements of stable ruthenium fission products in nuclear reactor fuel samples. [PDF]

open access: yesSci Rep
Patton GM   +5 more
europepmc   +1 more source

Safety, Tolerability, and Pharmacokinetics of the Long‐Acting SARS‐CoV‐2–Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in Healthy Chinese Adults

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract AZD7442, a combination of extended half‐life monoclonal antibodies tixagevimab and cilgavimab, was shown to neutralize previously circulating SARS‐CoV‐2 variants. This study evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD7442 in healthy Chinese adults. In this randomized, placebo‐controlled, Phase 1 study, AZD7442
Nanyang Li   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy